Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019

dc.creatorAbbafati, Cristiana
dc.creatorAbbas, Kaja M.
dc.creatorAbbasi, Mohammad
dc.creatorAbbasifard, Mitra
dc.creatorAbbasi-Kangevari, Mohsen
dc.creatorAbbastabar, Hedayat
dc.creatorAbd-Allah, Foad
dc.creatorAbdelalim, Ahmed
dc.creatorAbdollahi, Mohammad
dc.creatorAbdollahpour, Ibrahim
dc.date2021-02-05T23:11:02Z
dc.date2021-02-05T23:11:02Z
dc.date2020
dc.date.accessioned2023-10-03T20:08:17Z
dc.date.available2023-10-03T20:08:17Z
dc.identifier0140-6736
dc.identifier1474-547X
dc.identifierhttps://hdl.handle.net/11323/7832
dc.identifierCorporación Universidad de la Costa
dc.identifierREDICUC - Repositorio CUC
dc.identifierhttps://repositorio.cuc.edu.co/
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/9174449
dc.formatapplication/pdf
dc.formatapplication/pdf
dc.languageeng
dc.publisherCorporación Universidad de la Costa
dc.relation1 Kyu HH, Abate D, Abate KH, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392: 1859–922.
dc.relation2 James SL, Abate D, Abate KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392: 1789–858.
dc.relation3 Roth GA, Abate D, Abate KH, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392: 1736–88.
dc.relation4 WHO. Third United Nations high-level meeting on NCDs. 2018. http://www.who.int/ncds/governance/third-un-meeting/en (accessed May 17, 2018).
dc.relation5 WHO. Action plan for the prevention and control of noncommunicable diseases in the WHO European Region. Copenhagen: WHO Regional Office for Europe, 2016.
dc.relation6 Vayena E, Dzenowagis J, Brownstein JS, Sheikh A. Policy implications of big data in the health sector. Bull World Health Organ 2018; 96: 66–68.
dc.relation7 United Nations General Assembly. Political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases. New York: United Nations, 2018.
dc.relation8 Stevens GA, Alkema L, Black RE, et al. Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement. Lancet 2016; 388: e19–23.
dc.relation9 WHO. International Classification of Diseases (ICD). 2018. http://www.who.int/classifications/icd/en (accessed Feb 25, 2020).
dc.relation10 Rudd K, Johnson S, Agesa K, et al. Global, regional, and national sepsis incidence and mortality, 1990–2017. Lancet 2020; 395: 200–11.
dc.relation11 Fullman N, Yearwood J, Abay SM, et al. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016. Lancet 2018; 391: 2236–71.
dc.relation12 Afshin A, Sur PJ, Fay KA, et al. Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet 2019; 393: 1958–72.
dc.relation13 GBD 2019 Demographics Collaborators. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396: 1160–203.
dc.relation14 Jones GH, Bruera E, Abdi S, Kantarjian HM. The opioid epidemic in the United States—overview, origins, and potential solutions. Obstet Gynecol Surv 2019; 74: 278.
dc.relation15 Lyden J, Binswanger IA. The United States opioid epidemic. Semin Perinatol 2019; 43: 123–31.
dc.relation16 National Institute on Drug Abuse. Opioid overdose crisis. February, 2020. https://www.drugabuse.gov/drugs-abuse/opioids/opioid-overdose-crisis (accessed Feb 21, 2020).
dc.relation17 Public Health Agency of Canada. Apparent opioid-related deaths in Canada. December, 2019. https://health-infobase.canada.ca/substance-related-harms/opioids/ (accessed Dec 3, 2019).
dc.relation18 Soliman G, Elzalabany MS, Hassanein T, Miller FD. Mass screening for hepatitis B and C in Southern Upper Egypt. BMC Public Health 2019; 19: 1326.
dc.relation19 Abdel-Razek W, Hassany M, Kabil K, et al. The world’s largest hepatitis C screening program in Egypt. 2019. https://www.postersessiononline.eu/173580348_eu/congresos/ILC2019/aula/-LBP_8_ILC2019.pdf (accessed Nov 1, 2019).
dc.relation20 Omran D, Alboraie M, Zayed RA, et al. Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations. World J Gastroenterol 2018; 24: 4330–40.
dc.relation21 Elgharably A, Gomaa AI, Crossey MM, Norsworthy PJ, Waked I, Taylor-Robinson SD. Hepatitis C in Egypt—past, present, and future. Int J Gen Med 2016; 10: 1–6.
dc.relation22 Rao MR, Naficy AB, Darwish MA, et al. Further evidence for association of hepatitis C infection with parenteral schistosomiasis treatment in Egypt. BMC Infect Dis 2002; 2: 29.
dc.relation23 Plotzker RE, Murphy RD, Stoltey JE. Congenital syphilis prevention: strategies, evidence, and future directions. Sex Transm Dis 2018; 45 (suppl 1): S29–37.
dc.relation24 Korenromp EL, Rowley J, Alonso M, et al. Global burden of maternal and congenital syphilis and associated adverse birth outcomes—estimates for 2016 and progress since 2012. PLoS One 2019; 14: e0211720.
dc.relation25 Vollset S, Goren E, Yuan C-W, et al. Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100: a forecasting analysis for the Global Burden of Disease Study. Lancet 2020; 396: 1285–306.
dc.relation26 Ferrari AJ, Norman RE, Freedman G, et al. The burden attributable to mental and substance use disorders as risk factors for suicide: findings from the Global Burden of Disease Study 2010. PLoS One 2014; 9: e91936.
dc.relation27 Sha F, Chang Q, Law YW, Hong Q, Yip PSF. Suicide rates in China, 2004–2014: comparing data from two sample-based mortality surveillance systems. BMC Public Health 2018; 18: 239.
dc.relation28 Sha F, Yip PSF, Law YW. Decomposing change in China’s suicide rate, 1990–2010: ageing and urbanisation. Inj Prev 2017; 23: 40–45.
dc.relation29 Mew EJ, Padmanathan P, Konradsen F, et al. The global burden of fatal self-poisoning with pesticides 2006–15: systematic review. J Affect Disord 2017; 219: 93–104.
dc.relation30 Hogan MF, Grumet JG. Suicide prevention: an emerging priority for health care. Health Aff (Millwood) 2016; 35: 1084–90.
dc.relation31 WHO, UNAIDS. Progress on global access to HIV antiretroviral therapy. Geneva: World Health Organization, 2006.
dc.relation32 Stover J, Bollinger L, Izazola JA, Loures L, DeLay P, Ghys PD. What is required to end the AIDS epidemic as a public health threat by 2030? The cost and impact of the fast-track approach. PLoS One 2016; 11: e0154893.
dc.relation33 Steiner TJ, Stovner LJ, Vos T. GBD 2015: migraine is the third cause of disability in under 50s. J Headache Pain 2016; 17: 104.
dc.relation34 Lopez AD, Adair T. Is the long-term decline in cardiovasculardisease mortality in high-income countries over? Evidence from national vital statistics. Int J Epidemiol 2019; 48: 1815–23.
dc.relation35 Leong DP, Joseph PG, McKee M, et al. Reducing the global burden of cardiovascular disease, part 2. Circ Res 2017; 121: 695–710.
dc.relation36 GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet 2020; 396: 1223–49.
dc.relation37 Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc Diabetol 2018; 17: 83.
dc.relation38 Engelen SE, van der Graaf Y, Stam-Slob MC, et al. Incidence of cardiovascular events and vascular interventions in patients with type 2 diabetes. Int J Cardiol 2017; 248: 301–07.
dc.relation39 Harries AD, Lin Y, Kumar AMV, et al. What can National TB Control Programmes in low- and middle-income countries do to end tuberculosis by 2030? F1000Res 2018; 7: F1000 Faculty Rev-1011.
dc.relation40 Suthar AB, Zachariah R, Harries AD. Ending tuberculosis by 2030: can we do it? Int J Tuberc Lung Dis 2016; 20: 1148–54.
dc.relation41 WHO. Global tuberculosis report 2019. Geneva: World Health Organization, 2019.
dc.relation42 Ene-Iordache B, Perico N, Bikbov B, et al. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study. Lancet Glob Health 2016; 4: e307–19.
dc.relation43 Stanifer JW, Isenburg MV, Chertow GM, Anand S. Chronic kidney disease care models in low- and middle-income countries: a systematic review. BMJ Glob Health 2018; 3: e000728.
dc.relation44 Rehm J, Crépault J-F, Hasan OSM, Lachenmeier DW, Room R, Sornpaisarn B. Regulatory policies for alcohol, other psychoactive substances and addictive behaviours: the role of level of use and potency. A systematic review. Int J Environ Res Public Health 2019; 16: 3749.
dc.relation45 Lin FR. Time for a top-down approach to hearing aid affordability and accessibility. Am J Public Health 2018; 108: 166–68.
dc.relation46 Cummings J, Lee G, Ritter A, Zhong K. Alzheimer’s disease drug development pipeline: 2018. Alzheimers Dement (NY) 2018; 4: 195–214.
dc.relation47 Larsson SC, Markus HS. Does treating vascular risk factors prevent dementia and Alzheimer’s disease? A systematic review and meta-analysis. J Alzheimers Dis 2018; 64: 657–68.
dc.relation48 Yaffe K. Modifiable risk factors and prevention of dementia: what is the latest evidence? JAMA Intern Med 2018; 178: 281–82.
dc.relation49 Brasure M, Desai P, Davila H, et al. Physical activity interventions in preventing cognitive decline and Alzheimer-type dementia: a systematic review. Ann Intern Med 2018; 168: 30.
dc.relation50 Seppala LJ, van de Glind EMM, Daams JG, et al. Fall-risk-increasing drugs: a systematic review and meta-analysis: III. Others. J Am Med Dir Assoc 2018; 19: 372.e1–8.
dc.relation51 Xu T, Clemson L, O’Loughlin K, Lannin NA, Dean C, Koh G. Risk factors for falls in community stroke survivors: a systematic review and meta-analysis. Arch Phys Med Rehabil 2018; 99: 563–73.e5.
dc.relation52 Lan X, Li H, Wang Z, Chen Y. Frailty as a predictor of future falls in hospitalized patients: A systematic review and meta-analysis. Geriatr Nur 2019; published online Feb 11. DOI:10.1016/j.gerinurse.2019.01.004.
dc.relation53 Cheng P, Tan L, Ning P, et al. Comparative effectiveness of published interventions for elderly fall prevention: a systematic review and network meta-analysis. Int J Environ Res Public Health 2018; 15: 498.
dc.relation54 WHO. Noncommunicable diseases. June 1, 2018. https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases(accessed Jan 27, 2020).
dc.relation55 Nugent R, Bertram MY, Jan S, et al. Investing in non-communicable disease prevention and management to advance the Sustainable Development Goals. Lancet 2018; 391: 2029–35.
dc.relation56 Cottingham MD, Kalbaugh CA, Fisher JA. Tracking the pharmaceutical pipeline: clinical trials and global disease burden. Clin Transl Sci 2014; 7: 297–99.
dc.relation57 Fisher JA, Cottingham MD, Kalbaugh CA. Peering into the pharmaceutical “pipeline”: investigational drugs, clinical trials, and industry priorities. Soc Sci Med 2015; 131: 322–30.
dc.relation58 Long G. The biopharmaceutical pipeline: innovative therapies in clinical development. Boston, MA: Analysis Group, 2017.
dc.relation59 Singh GK, Siahpush M, Azuine RE, Williams SD. Increasing area deprivation and socioeconomic inequalities in heart disease, stroke, and cardiovascular disease mortality among working age populations, United States, 1969–2011. Int J MCH AIDS 2015; 3: 119–33.
dc.relation60 Schultze-Kraft M, Chinchilla FA, Moriconi M. New perspectives on crime, violence and insecurity in Latin America. Crime Law Soc Change 2018; 69: 465–73.
dc.rightsCC0 1.0 Universal
dc.rightshttp://creativecommons.org/publicdomain/zero/1.0/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rightshttp://purl.org/coar/access_right/c_abf2
dc.sourceThe Lancet
dc.sourcehttps://www.sciencedirect.com/science/article/pii/S147444221830454X
dc.subjectRisk-factors
dc.subjectClinical-trials
dc.subjectPrevention
dc.subjectDisability
dc.subjectDementia
dc.subjectFalls
dc.titleGlobal burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019
dc.typeArtículo de revista
dc.typehttp://purl.org/coar/resource_type/c_6501
dc.typeText
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typehttp://purl.org/redcol/resource_type/ART
dc.typeinfo:eu-repo/semantics/acceptedVersion
dc.typehttp://purl.org/coar/version/c_ab4af688f83e57aa


Este ítem pertenece a la siguiente institución